A

Long-term cognitive function after treatment with immune checkpoint inhibition for melanoma

Journal of Cancer Survivorship

Authors 6

  1. Maryse J. Luijendijk corresponding

    The Netherlands Cancer Institute

    Affiliation as printed

    Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands. m.luijendijk@nki.nl

  2. The Netherlands Cancer Institute

    Affiliation as printed

    Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands

  3. The Netherlands Cancer Institute

    Affiliation as printed

    Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands

  4. The Netherlands Cancer Institute · Tilburg University

    Affiliation as printed

    Department of Medical and Clinical Psychology, Tilburg University, Tilburg, the Netherlands

    Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands

  5. University of Regensburg · University Hospital Regensburg · Leiden University Medical Center · The Netherlands Cancer Institute

    Affiliation as printed

    Department of Hematology and Oncology, University Clinic Regensburg (UKR), Regensburg, Germany

    Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands

    Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands

  6. University of Amsterdam · The Netherlands Cancer Institute

    Affiliation as printed

    Brain and Cognition Group, University of Amsterdam, Amsterdam, the Netherlands

    Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-11).

References 39